Fundraising FoxAlzinova
Stockholm, SE · 1 known investors
Find your way into Alzinova
Sign up to see every warm intro you have to Alzinova
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Alzinova team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Alzinova is a clinical-stage biopharmaceutical company developing an active immunotherapy (vaccine) for Alzheimer's disease based on its proprietary AβCC Peptide technology. The company's lead candidate is in clinical testing in patients, and its shares are listed on Nasdaq First North Growth Market in Stockholm.
Investors · 1
In the news
Frequently asked questions
- What does Alzinova do?
- Alzinova is a clinical-stage biopharmaceutical company developing an active immunotherapy (vaccine) for Alzheimer's disease based on its proprietary AβCC Peptide technology. The company's lead candidate is in clinical testing in patients, and its shares are listed on Nasdaq First North Growth Market in Stockholm.
- Who are Alzinova's investors?
- Alzinova's investors include GU Ventures AB.
- Where is Alzinova headquartered?
- Alzinova is headquartered in Stockholm, SE.